PHARMACOLOGICAL EVIDENCE FOR THE EXISTENCE OF DIFFERENT SUBTYPES OF MUSCARINIC ACETYLCHOLINE-RECEPTORS FOR PHOSPHOINOSITIDE HYDROLYSIS IN NEONATAL VERSUS ADULT-RAT ATRIA
Jj. Camusso et al., PHARMACOLOGICAL EVIDENCE FOR THE EXISTENCE OF DIFFERENT SUBTYPES OF MUSCARINIC ACETYLCHOLINE-RECEPTORS FOR PHOSPHOINOSITIDE HYDROLYSIS IN NEONATAL VERSUS ADULT-RAT ATRIA, Journal of lipid mediators and cell signalling, 12(1), 1995, pp. 1-10
The negative inotropic effect of carbachol, as well as phosphoinositid
e hydrolysis, was measured in atria from neonatal and adult rats. Carb
achol increased phosphoinositide hydrolysis and decreased dF/dt of bot
h neonatal and adult atria; however, the neonatal atria showed hyperea
ctivity to carbachol as compared with adult atria. Inhibition of phosp
holipase C reduced the supersensitivity to carbachol upon contractilit
y in neonatal atria producing values similar to those of the adult atr
ia, suggesting that muscarinic acetylcholine receptor (mAchR) stimulat
ion is secondary to receptor-mediated hydrolysis of phosphoinositides.
Pharmacological analysis with mAchR antagonists tends to support the
idea that mi and m2 subtypes are the most important mediators of the r
esponse to carbachol in neonatal atria. In adult atria, the effect of
carbachol is coupled only to mAchR m2 subtypes.